CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 16,428	$ 25,009
Grant receivables	4,778	2,686
Prepaid expenses and other current assets	1,660	1,860
Total current assets	22,866	29,555
Property and equipment, net	190	181
Right-of-use assets, operating leases	444	498
Total assets	23,500	30,234
Current liabilities:
Accounts payable	1,821	1,984
Accrued expenses	7,708	7,620
Deferred grant income, current	1,066	1,066
Operating lease liabilities, current	194	193
Other current liabilities	161	279
Total current liabilities	10,950	11,142
Operating lease liabilities, non-current	280	342
Total liabilities	11,230	11,484
Commitments and contingencies (Note 6)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.001 par value, 250,000,000 shares authorized; 61,974,755 and 59,854,877 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	62	60
Additional paid-in capital	195,848	193,850
Accumulated deficit	(183,640)	(175,160)
Total stockholders' equity	12,270	18,750
Total liabilities and stockholders' equity	$ 23,500	$ 30,234

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).